Solentim
Wimborne
About Solentim
Commercial cell line development for biopharmaceutical production is a high value process that is intrinsically expensive and takes a significant amount of time. Solentim is dedicated to the development of smart tools that shorten the steps in the upstream cell line development workflow and accelerate timelines. Their products are the Cell Metric™ series for clone screening, growth and stability measurements.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Website: solentim.com
- Phone: (617)715-6927
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/solentim-1240809 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.